Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
about
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's DiseaseThe recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's diseaseAtypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective studySix psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.The psychosis spectrum in Parkinson disease.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Perioperative management of Parkinson's disease.Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.Treatment of Sleep Dysfunction in Parkinson's Disease.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes.Prevalence of and indications for antipsychotic use in Parkinson's disease.Structural and functional alterations of the heart in Parkinson's disease.Parkinson's disease psychosis: presentation, diagnosis and management.
P2860
Q26738456-DCE2944F-D1CD-436F-98AB-DC735C0B0126Q26745661-41E21EBE-E64E-4327-AC72-92D46B02EB68Q33810051-912686C0-36EE-4747-9767-6D9525161F7EQ37548320-84C97BEE-3F98-42A1-A7F6-C456F1B067ABQ38768169-2AF26B8B-BB98-402C-A1BD-B059AB386CB1Q38894971-DB109F72-766D-4189-8D6B-27F574745FC2Q38966013-E0DB8EB2-2008-4BFC-AA44-7183103254A7Q39004255-E674F82D-E5F6-490E-8A8C-95EC0FA09E2CQ39342961-425DDA94-7BD5-4126-BAE1-CB8DC0AD0A35Q43375910-D53F396C-E326-4694-BF2D-DA9296C29E1EQ47094610-CE1FBBE5-0F7B-44FC-BE55-607707B45D13Q48349028-BB581B47-B5F9-41B0-AD96-CD5767502200Q50066781-8C26FC47-FE96-4F1D-903E-588FB97471EAQ51781286-C47D9FCA-3284-49FA-9D04-B6687D7F7E49
P2860
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@en
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@nl
type
label
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@en
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@nl
prefLabel
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@en
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@nl
P2093
P2860
P1433
P1476
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
@en
P2093
Barbara Stanislawski
Claire Chiang
Eugenia Mamikonyan
Helen C Kales
Hyungjin Myra Kim
Jayne Wilkinson
P2860
P304
P356
10.1001/JAMANEUROL.2016.0031
P407
P577
2016-03-21T00:00:00Z